Skip to main content
Clinical Trials/JPRN-UMIN000005337
JPRN-UMIN000005337
Completed
未知

The effect on the renal functions and blood pressure of DPP-4 Inhibitor for the type 2 diabetic patients . - Sitagliptin therapy for blood glucose ,BP,and renal function in type 2 diabetic patients.(STABAR)

Kanazawa Medical University Diadetes & Endocrinology0 sites100 target enrollmentMarch 29, 2011
ConditionsType 2 diabetes

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 2 diabetes
Sponsor
Kanazawa Medical University Diadetes & Endocrinology
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 29, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kanazawa Medical University Diadetes & Endocrinology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Patients with type 1 diabetes 2\)History of severe ketosis, diabetic coma or precoma within 6 months 3\)Patients with severe infections, before or after operation, or with serious trauma 4\)Ptientswho are pregnant, breast\-feeding and/or intention to become pregnant 5\)Patients with the severe renal impairment 6\)Patients receiving Alfa\-glycosidase inhibitor, Glinide or Insulin 7\)Patients receiving DPP\-4 inhibitor other than Sitagliptin 8\)Patients having allergies against DPP\-4 inhibitor or alfa\-Glycosidase inhibitor 9\)Patients determined to be inappropriate for the study by physician based on the scientific grounds.

Outcomes

Primary Outcomes

Not specified

Similar Trials